DOI: 10.4244/EIJ-D-20-00621L

Letter: Cardiac CT prior to percutaneous coronary sinus-based mitral annuloplasty with the Carillon device

Michał Kuzemczak1,2, MD, PhD, MSc; Tomasz Siminiak2, MD, PhD

We read with great interest the article by Rottländer et al entitled “CT-Angiographic imaging of the Carillon device topography after unsuccessful treatment of FMR”1, suggesting that parameters such as coronary sinus (CS) to mitral valve annulus distance and angle might predict response to Carillon device implantation. However, the measurements were obtained nine months following the procedure when they might not reflect native preprocedural anatomical relationships. The Carillon device applies tension on the vein and frequently alters relations between adjacent structures. As an example, the vein can be displaced by the device which causes the artery to be no longer compressed, despite the preprocedural computed tomography (CT) showing otherwise. The AMADEUS trial also revealed no significant differences between responders and non-responders in terms of the position of the venous system in relation to the posterior mitral annulus2. Furthermore, counter-intuitively, the Carillon device was also effective when the coronary sinus and great cardiac vein were located above the plane of the mitral annulus. Given the above, a CT scan was no longer mandatory in later clinical trials which, in our belief, does not imply complete uselessness of the imaging technique.

Analysis of our own series of cases has shown that only the tenting area assessed by preprocedural echocardiography was correlated with the degree of improvement after Carillon implantation3. While we agree that cardiac CT has potential to yield important preprocedural data for planning and facilitating the procedure, assessment of the effect of reciprocal annular-CS relations by CT on the procedural results requires verification in a clinical trial. Rottländer et al should be congratulated for the excellent presentation of relevant measurements.

Conflict of interest statement

T. Siminiak was a proctor and an investigator in clinical trials sponsored by Cardiac Dimensions, Inc., and received personal fees from Cardiac Dimensions, Inc., during the conduct of the study. The other author has no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Volume 16 Number 10
Nov 20, 2020
Volume 16 Number 10
View full issue


Key metrics

Suggested by Cory

Image – Interventional flashlight

10.4244/EIJ-D-20-00332 Mar 19, 2021
Computed tomography angiography imaging of the Carillon device topography after unsuccessful treatment of functional mitral regurgitation
Rottländer D et al
free

MITRAL VALVE INTERVENTIONS

10.4244/EIJV12SYA16 Sep 18, 2016
The Carillon: strategies for optimal patient selection and optimised results
Rottlaender D et al
free

10.4244/EIJV11SWA18 Sep 17, 2015
The CARILLON Mitral Contour transcatheter indirect mitral valve annuloplasty system
Goldberg S et al
free

MITRAL VALVE INTERVENTIONS

10.4244/EIJV12SYA17 Sep 18, 2016
The Mitralign: strategies for optimal patient selection and optimised results
Schueler R and Nickenig G
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved